---
---

# 21 U.S.C., USLM ref /us/usc/t21/s360cc

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../../../..//us/usc/t21/ch9/schV/ptB/m__us_usc_t21_s360bb.md) | [Next](./../../../../../..//us/usc/t21/ch9/schV/ptB/m__us_usc_t21_s360dd.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360cc)

## § 360cc. Protection for drugs for rare diseases or conditions

    (a) __Exclusive approval, certification, or license__ 

    Except as provided in subsection (b) of this section, if the Secretary—

        (1) approves an application filed pursuant to [section 355 of this title][/us/usc/t21/s355], or

        (2) issues a license under [section 262 of title 42][/us/usc/t42/s262]

        for a drug designated under [section 360bb of this title][/us/usc/t21/s360bb] for a rare disease or condition, the Secretary may not approve another application under [section 355 of this title][/us/usc/t21/s355] or issue another license under [section 262 of title 42][/us/usc/t42/s262] for such drug for such disease or condition for a person who is not the holder of such approved application or of such license until the expiration of seven years from the date of the approval of the approved application or the issuance of the license. [Section 355(c)(2) of this title][/us/usc/t21/s355/c/2] does not apply to the refusal to approve an application under the preceding sentence.

    (b) __Exceptions__ 

    If an application filed pursuant to [section 355 of this title][/us/usc/t21/s355] is approved for a drug designated under [section 360bb of this title][/us/usc/t21/s360bb] for a rare disease or condition or if a license is issued under [section 262 of title 42][/us/usc/t42/s262] for such a drug, the Secretary may, during the seven-year period beginning on the date of the application approval or of the issuance of the license, approve another application under [section 355 of this title][/us/usc/t21/s355] or issue a license under [section 262 of title 42][/us/usc/t42/s262], for such drug for such disease or condition for a person who is not the holder of such approved application or of such license if—

        (1) the Secretary finds, after providing the holder notice and opportunity for the submission of views, that in such period the holder of the approved application or of the license cannot assure the availability of sufficient quantities of the drug to meet the needs of persons with the disease or condition for which the drug was designated; or

        (2) such holder provides the Secretary in writing the consent of such holder for the approval of other applications or the issuance of other licenses before the expiration of such seven-year period.

([June 25, 1938, ch. 675, § 527][/us/act/1938-06-25/ch675/s527], as added [Pub. L. 97–414, § 2(a)][/us/pl/97/414/s2/a], Jan. 4, 1983, [96 Stat. 2050][/us/stat/96/2050]; amended [Pub. L. 98–417, title I, § 102(b)(6)][/us/pl/98/417/s102/b/6], Sept. 24, 1984, [98 Stat. 1593][/us/stat/98/1593]; [Pub. L. 99–91][/us/pl/99/91], §§ 2, 3(a)(3), Aug. 15, 1985, [99 Stat. 387][/us/stat/99/387], 388; [Pub. L. 103–80, § 3(v)][/us/pl/103/80/s3/v], Aug. 13, 1993, [107 Stat. 778][/us/stat/107/778]; [Pub. L. 105–115, title I, § 125(b)(2)(J)][/us/pl/105/115/s125/b/2/J], (K), Nov. 21, 1997, [111 Stat. 2326][/us/stat/111/2326]; [Pub. L. 107–281, § 4][/us/pl/107/281/s4], Nov. 6, 2002, [116 Stat. 1993][/us/stat/116/1993].)

 __Amendments__ 

    2002—Subsec. (a). [Pub. L. 107–281][/us/pl/107/281], in concluding provisions, struck out “, of such certification,” after “such approved application” and “, the issuance of the certification,” after “approval of the approved application”.

    1997—Subsec. (a). [Pub. L. 105–115, § 125(b)(2)(J)][/us/pl/105/115/s125/b/2/J], struck out “, issue another certification under [section 357 of this title][/us/usc/t21/s357],” before “or issue another license” in closing provisions, inserted “or” at end of par. (1), redesignated par. (3) as (2), and struck out former par. (2) which read as follows: “issues a certification under [section 357 of this title][/us/usc/t21/s357], or”.

    Subsec. (b). [Pub. L. 105–115, § 125(b)(2)(K)][/us/pl/105/115/s125/b/2/K], in introductory provisions, struck out “, if a certification is issued under [section 357 of this title][/us/usc/t21/s357] for such a drug,” after “rare disease or condition”, “, of the issuance of the certification under [section 357 of this title][/us/usc/t21/s357],” after “application approval”, “, issue another certification under [section 357 of this title][/us/usc/t21/s357],” after “application under [section 355 of this title][/us/usc/t21/s355]”, and “, of such certification,” after “approved application”.

    Subsec. (b)(1). [Pub. L. 105–115, § 125(b)(2)(K)][/us/pl/105/115/s125/b/2/K], struck out “, of the certification,” after “holder of the approved application”.

    Subsec. (b)(2). [Pub. L. 105–115, § 125(b)(2)(K)][/us/pl/105/115/s125/b/2/K], struck out “, issuance of other certifications,” after “approval of other applications”.

    1993—Subsec. (b). [Pub. L. 103–80][/us/pl/103/80] struck out extraneous comma before “or issue a license under section 262” in introductory provisions and substituted “the” for “The” at beginning of par. (1).

    1985—[Pub. L. 99–91, § 2(3)][/us/pl/99/91/s2/3], struck out “unpatented” before “drugs” in section catchline.

    Subsec. (a). [Pub. L. 99–91][/us/pl/99/91], §§ 2(1), 3(a)(3)(A)–(D), struck out “or” at end of par. (1), added par. (2), redesignated former par. (2) as (3), struck out “and for which a United States Letter of Patent may not be issued” after “rare disease or condition”, inserted in first sentence “, issue another certification under [section 357 of this title][/us/usc/t21/s357],” after “[section 355 of this title][/us/usc/t21/s355]” the second time it appeared, inserted “, of such certification,” after “holder of such approved application”, and inserted “, the issuance of the certification,” after “approval of the approved application”.

    Subsec. (b). [Pub. L. 99–91][/us/pl/99/91], §§ 2(2), 3(a)(3)(E)–(K), struck out “and if a United States Letter of Patent may not be issued for the drug” after “such a drug”, substituted “, if a certification is issued under [section 357 of this title][/us/usc/t21/s357] for such a drug, or if a license” for “or a license”, inserted “, of the issuance of the certification under [section 357 of this title][/us/usc/t21/s357],” after “application approval”, struck out “, if the drug is a biological product,” before “issue a license”, inserted “, issue another certification under [section 357 of this title][/us/usc/t21/s357],” after “[section 355 of this title][/us/usc/t21/s355]”, inserted “, of such certification,” after “holder of such approved application”, inserted “, of such certification,” after “application” in par. (1), and inserted “, issuance of other certifications,” after “other applications” in par. (2).

    1984—Subsecs. (a), (b). [Pub. L. 98–417][/us/pl/98/417] substituted “section 355” for “section 355(b)” wherever appearing.

 __Effective Date of 1985 Amendment__ 

    Amendment by [Pub. L. 99–91][/us/pl/99/91] effective Aug. 15, 1985, see [section 8(b) of Pub. L. 99–91][/us/pl/99/91/s8/b], set out as a note under [section 360aa of this title][/us/usc/t21/s360aa].

----------

[Previous](./../../../../../..//us/usc/t21/ch9/schV/ptB/m__us_usc_t21_s360bb.md) | [Next](./../../../../../..//us/usc/t21/ch9/schV/ptB/m__us_usc_t21_s360dd.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360cc)

----------
----------

[/us/usc/t21/s355]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs355
[/us/usc/t42/s262]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs262
[/us/usc/t21/s360bb]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360bb
[/us/usc/t21/s355]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs355
[/us/usc/t42/s262]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs262
[/us/usc/t21/s355/c/2]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs355%2Fc%2F2
[/us/usc/t21/s355]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs355
[/us/usc/t21/s360bb]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360bb
[/us/usc/t42/s262]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs262
[/us/usc/t21/s355]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs355
[/us/usc/t42/s262]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs262
[/us/act/1938-06-25/ch675/s527]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fact%2F1938-06-25%2Fch675%2Fs527
[/us/pl/97/414/s2/a]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F97%2F414%2Fs2%2Fa
[/us/stat/96/2050]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F96%2F2050
[/us/pl/98/417/s102/b/6]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F98%2F417%2Fs102%2Fb%2F6
[/us/stat/98/1593]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F98%2F1593
[/us/pl/99/91]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F99%2F91
[/us/stat/99/387]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F99%2F387
[/us/pl/103/80/s3/v]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F103%2F80%2Fs3%2Fv
[/us/stat/107/778]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F107%2F778
[/us/pl/105/115/s125/b/2/J]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F105%2F115%2Fs125%2Fb%2F2%2FJ
[/us/stat/111/2326]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F111%2F2326
[/us/pl/107/281/s4]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F107%2F281%2Fs4
[/us/stat/116/1993]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F116%2F1993
[/us/pl/107/281]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F107%2F281
[/us/pl/105/115/s125/b/2/J]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F105%2F115%2Fs125%2Fb%2F2%2FJ
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/pl/105/115/s125/b/2/K]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F105%2F115%2Fs125%2Fb%2F2%2FK
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/usc/t21/s355]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs355
[/us/pl/105/115/s125/b/2/K]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F105%2F115%2Fs125%2Fb%2F2%2FK
[/us/pl/105/115/s125/b/2/K]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F105%2F115%2Fs125%2Fb%2F2%2FK
[/us/pl/103/80]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F103%2F80
[/us/pl/99/91/s2/3]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F99%2F91%2Fs2%2F3
[/us/pl/99/91]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F99%2F91
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/usc/t21/s355]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs355
[/us/pl/99/91]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F99%2F91
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/usc/t21/s357]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs357
[/us/usc/t21/s355]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs355
[/us/pl/98/417]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F98%2F417
[/us/pl/99/91]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F99%2F91
[/us/pl/99/91/s8/b]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F99%2F91%2Fs8%2Fb
[/us/usc/t21/s360aa]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360aa


